LP
PRCT icon

LMR Partners’s Procept Biorobotics PRCT Stock Holding History

LMR Partners’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.3M Buy
+721,608
New +$18.1M 0.06% 289
2025
Q2 		– Sell
-8,427
Closed -$491K – 1593
2025
Q1 		$491K Buy
+8,427
New +$575K ﹤0.01% 919
2024
Q4 		– Sell
-23,361
Closed -$1.87M – 1519
2024
Q3 		$1.87M Buy
23,361
+9,072
+63% +$645K 0.01% 625
2024
Q2 		$873K Buy
+14,289
New +$850K 0.01% 688
2021
Q4 		– Sell
-32,800
Closed -$1.25M – 1249
2021
Q3 		$1.25M Buy
+32,800
New +$1.26M 0.01% 576

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

LMR Partners's PRCT Position: Q2 2026 in Review

LMR Partners opened a new position in Procept Biorobotics (PRCT) in Q2 2026: 721,608 shares worth $16.3M. The stake represents 0.06% of the portfolio and ranks #289 among its holdings. This is a return to the name: LMR Partners previously reported a position in PRCT as recently as Q1 2025.

LMR Partners first reported a position in PRCT in Q3 2021 and has held it in 5 quarters since. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • LMR Partners held 721,608 shares of Procept Biorobotics worth $16.3M as of Q2 2026.
  • Procept Biorobotics was a new LMR Partners position in Q2 2026.
  • Procept Biorobotics made up 0.06% of LMR Partners's portfolio in Q2 2026, its #289 holding.
  • LMR Partners first reported a position in Procept Biorobotics in Q3 2021 and has held it in 5 quarters since.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.